A study conducted by Zhang, Y [39] determined that Epimedium may improve brain glucose metabolism by increasing glucose transport and promoting glucose catabolism, and suggested that this improves the learning memory function in mice through the APP/PS1/Tau triple-transgenic AD (3 × Tg-AD) model. Here, MAPT is linked to Alzheimer disease.